Established in 2006, Ilooda Co., Ltd. is a specialized manufacturer of laser and high-frequency medical devices. Its core business involves the research, development, and production of specialized medical equipment for dermatology, aesthetics, plastic surgery, and dentistry. In 2024, Ilooda was absorbed and merged into Classys Co., Ltd., becoming part of the integrated entity. This merger contributes to strengthening the product portfolio across all energy-based medical device (EBD) sectors.Establishedin2006,IloodaCo.,Ltd.isaspecializedmanufactureroflaserandhigh-frequencymedicaldevices.Itscorebusinessinvolvestheresearch,development,andproductionofspecializedmedicalequipmentfordermatology,aesthetics,plasticsurgery,anddentistry.In2024,IloodawasabsorbedandmergedintoClassysCo.,Ltd.,becomingpartoftheintegratedentity.Thismergercontributestostrengtheningtheproductportfolioacrossallenergy-basedmedicaldevice(EBD)sectors.
Key Products/TechnologiesKeyProducts/Technologies
High-frequency surgical unit Secret (MTR-Series): A Micro-Needle Fractional RF (MNRF) system for skin rejuvenation and tightening, acne scar treatment, wrinkle reduction, and improved skin elasticityHigh-frequencysurgicalunitSecret(MTR-Series):AMicro-NeedleFractionalRF(MNRF)systemforskinrejuvenationandtightening,acnescartreatment,wrinklereduction,andimprovedskinelasticity
Semiconductor laser surgical unit VIKINI (DET-C1): An 808nm diode laser device for hair removal and vascular lesion treatment, featuring a contact sapphire cooling systemSemiconductorlasersurgicalunitVIKINI(DET-C1):An808nmdiodelaserdeviceforhairremovalandvascularlesiontreatment,featuringacontactsapphirecoolingsystem
Nd:YAG laser surgical unit CuRAS (QND-C1): An advanced Q-switched 1064nm + 532nm Nd:YAG laser system for pigmented lesions and tattoo removalNd:YAGlasersurgicalunitCuRAS(QND-C1):AnadvancedQ-switched1064nm+532nmNd:YAGlasersystemforpigmentedlesionsandtattooremoval
CO2 laser surgical unit FRAXIS (FRX-C1): A fractional CO2 laser system for skin resurfacing and vaginal rejuvenationCO2lasersurgicalunitFRAXIS(FRX-C1):AfractionalCO2lasersystemforskinresurfacingandvaginalrejuvenation
CO2 laser surgical unit FRAXIS DUO (Fraxis Duo): A perfect synergy of fractional CO2 laser and micro-needle fractional RF technology, addressing skin resurfacing, scar treatment, and pigmentation issuesCO2lasersurgicalunitFRAXISDUO(FraxisDuo):AperfectsynergyoffractionalCO2laserandmicro-needlefractionalRFtechnology,addressingskinresurfacing,scartreatment,andpigmentationissues
Reepot: The world's first pigmentation-targeted laser with super cooling technology, specialized for treating pigmentation disorders like freckles and age spotsReepot:Theworld'sfirstpigmentation-targetedlaserwithsupercoolingtechnology,specializedfortreatingpigmentationdisorderslikefrecklesandagespots
Hyzer Me: A High-Intensity Focused Ultrasound (HIFU) device for skin tightening, equipped with an ultra-lightweight dual handpiece and linear motor technologyHyzerMe:AHigh-IntensityFocusedUltrasound(HIFU)deviceforskintightening,equippedwithanultra-lightweightdualhandpieceandlinearmotortechnology
Secret Pro: An upgraded version of the existing Fraxis Duo, combining a Fractional CO2 laser and a Fractional Needle RF System, used for acne and trauma scar removal, large pore treatment, and skin liftingSecretPro:AnupgradedversionoftheexistingFraxisDuo,combiningaFractionalCO2laserandaFractionalNeedleRFSystem,usedforacneandtraumascarremoval,largeporetreatment,andskinlifting
Core AdvantagesCoreAdvantages
Proprietary Technology Development Capability: Possession of proprietary technologies in energy-based medical devices, including laser, high-frequency, and HIFUProprietaryTechnologyDevelopmentCapability:Possessionofproprietarytechnologiesinenergy-basedmedicaldevices,includinglaser,high-frequency,andHIFU
Diversified Product Portfolio: Establishment of a broad range of medical device lineups covering dermatology, aesthetics, plastic surgery, and dentistryDiversifiedProductPortfolio:Establishmentofabroadrangeofmedicaldevicelineupscoveringdermatology,aesthetics,plasticsurgery,anddentistry
Consumable-Based Revenue Model: A sustainable revenue structure through equipment sales and high-margin consumable (needles, cartridges) sales, exemplified by Secret RFConsumable-BasedRevenueModel:Asustainablerevenuestructurethroughequipmentsalesandhigh-marginconsumable(needles,cartridges)sales,exemplifiedbySecretRF
Global Distribution Network and Market Expansion: Establishment of a robust global business network with approximately 60 distribution partners in 48 countries worldwideGlobalDistributionNetworkandMarketExpansion:Establishmentofarobustglobalbusinessnetworkwithapproximately60distributionpartnersin48countriesworldwide
Proactive R&D Investment and Industry-Academia Collaboration: Over 33% of total employees dedicated to research and development, with a cooperative network established with universities and external research institutionsProactiveR&DInvestmentandIndustry-AcademiaCollaboration:Over33%oftotalemployeesdedicatedtoresearchanddevelopment,withacooperativenetworkestablishedwithuniversitiesandexternalresearchinstitutions
Patient-Centric Clinical Research: Development of treatment methods based on individual patient conditions, maximizing treatment efficiency while minimizing side effects and painPatient-CentricClinicalResearch:Developmentoftreatmentmethodsbasedonindividualpatientconditions,maximizingtreatmentefficiencywhileminimizingsideeffectsandpain
Target IndustrieTargetIndustrie
DermatologyDermatology
Aesthetics and Plastic SurgeryAestheticsandPlasticSurgery
DentistryDentistry
Ophthalmology (investment in ophthalmic disease diagnostic medical device development)Ophthalmology(investmentinophthalmicdiseasediagnosticmedicaldevicedevelopment)
Home Beauty Market (launch of 'nuuz' brand)HomeBeautyMarket(launchof'nuuz'brand)
Major MarketsMajorMarkets
Japan, Thailand, Saudi Arabia, China (VIKINI NMPA approval)Japan,Thailand,SaudiArabia,China(VIKININMPAapproval)
Europe (CE Mark certification), Russia (Hyzer Me approval)Europe(CEMarkcertification),Russia(HyzerMeapproval)
United States (partnership with Cutera, FDA approval, Secret Family product sales), Canada (VIKINI HC approval)UnitedStates(partnershipwithCutera,FDAapproval,SecretFamilyproductsales),Canada(VIKINIHCapproval)
Certifications/PatentsCertifications/Patents
FDA 510k Clearance: Secret Pro (laser surgical device), Reepot (laser device), VIKINI (semiconductor laser surgical unit)FDA510kClearance:SecretPro(lasersurgicaldevice),Reepot(laserdevice),VIKINI(semiconductorlasersurgicalunit)
CE Mark Certification: Obtained CE Mark for entry into the European marketCEMarkCertification:ObtainedCEMarkforentryintotheEuropeanmarket
Health Canada (HC) Approval: VIKINI (semiconductor laser surgical unit)HealthCanada(HC)Approval:VIKINI(semiconductorlasersurgicalunit)
China NMPA (National Medical Products Administration) Approval: VIKINI (semiconductor laser surgical unit)ChinaNMPA(NationalMedicalProductsAdministration)Approval:VIKINI(semiconductorlasersurgicalunit)
Thai TFDA (Thai Food and Drug Administration) Sales Approval: Reepot (laser device)ThaiTFDA(ThaiFoodandDrugAdministration)SalesApproval:Reepot(laserdevice)
Russian Approval: Hyzer Me (skin-tightening device)RussianApproval:HyzerMe(skin-tighteningdevice)
Saudi SFDA Certification: Reepot (laser device)SaudiSFDACertification:Reepot(laserdevice)
Patent: WO-2024181852-A1 (High-frequency skin treatment device and method of controlling same)Patent:WO-2024181852-A1(High-frequencyskintreatmentdeviceandmethodofcontrollingsame)
Patent: WO-2021245460-A2/A3/A8 (Laser treatment of skin lesions under dermal vasoconstriction)Patent:WO-2021245460-A2/A3/A8(Lasertreatmentofskinlesionsunderdermalvasoconstriction)
Patent: WO-2022144587-A1 (Laser device for laser treatment of skin lesions under dermal vasoconstriction)Patent:WO-2022144587-A1(Laserdeviceforlasertreatmentofskinlesionsunderdermalvasoconstriction)
Patent: Secured licenses for 6 US patents, including US Patent No. 9,480,836, through a settlement agreement with Serendia LLC (invasive RF technology)Patent:Securedlicensesfor6USpatents,includingUSPatentNo.9,480,836,throughasettlementagreementwithSerendiaLLC(invasiveRFtechnology)
Patent: 10589095 (Device for treating disorders of secreting gland in eyelid)Patent:10589095(Devicefortreatingdisordersofsecretingglandineyelid)
Patent: 10525276 (Method of detecting a lesion position through lesion image analysis)Patent:10525276(Methodofdetectingalesionpositionthroughlesionimageanalysis)
Patent Application: 20240138676 (Camera for diagnosing ophthalmic and control method for the same)PatentApplication:20240138676(Camerafordiagnosingophthalmicandcontrolmethodforthesame)
Patent Application: 20220241618 (High-intensity focused ultrasound device and method for controlling transducer moving piezoelectric device used in the same)PatentApplication:20220241618(High-intensityfocusedultrasounddeviceandmethodforcontrollingtransducermovingpiezoelectricdeviceusedinthesame)